Drug Free Solution, Inc. (DSOL) Hisse Analizi
Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Drug Free Solution, Inc. (DSOL), Healthcare sektöründe faaliyet gösteriyor, son olarak $'dan işlem görüyor ve 0 piyasa değerine sahip. Büyüme potansiyeli, finansal sağlık ve momentum konusunda 45/100 (ihtiyatlı) olarak derecelendirilmiştir.
Son analiz: 16 Mar 2026Drug Free Solution, Inc. (DSOL) Sağlık ve Boru Hattı Genel Bakışı
Drug Free Solution, Inc. delivers emotional wellness technology, the Living Breath Process, targeting addiction prevention, self-help, and lifestyle markets. The company offers programs, education, and services through its Living Breath Series and aims to establish community wellness centers and support networks. It operates within the healthcare information services sector.
Yatırım Tezi
Drug Free Solution, Inc. presents a unique approach to emotional wellness through its Living Breath Process. The company's focus on addiction prevention and self-help markets positions it within a growing segment of the healthcare industry. Key value drivers include the expansion of its Living Breath Series programs and the establishment of community wellness centers. However, the company's small market capitalization of $0.00B and negative P/E ratio of -59.29 indicate financial challenges. Future success depends on the company's ability to effectively market its programs, secure partnerships, and demonstrate tangible results in reducing addiction and improving emotional wellness. The company's beta of 0.07 suggests low volatility relative to the market.
FMP finansallarına ve nicel analizine dayanmaktadır
Temel Önemli Noktalar
- Market capitalization of $0.00B reflects the company's small size and limited market presence.
- P/E ratio of -59.29 indicates that the company is currently not profitable.
- Beta of 0.07 suggests low volatility compared to the overall market.
- The company's focus on emotional wellness aligns with growing demand for mental health solutions.
- The Living Breath Process represents a proprietary technology with potential for expansion into various markets.
Rakipler & Benzerleri
Güçlü Yönler
- Proprietary Living Breath Process technology.
- Focus on addiction prevention and emotional wellness.
- Potential for community-based partnerships.
- Experienced leadership team.
Zayıflıklar
- Small market capitalization and limited financial resources.
- Negative P/E ratio indicating lack of profitability.
- Limited brand recognition compared to larger competitors.
- Dependence on a single core technology.
Katalizörler
- Ongoing: Expansion of Living Breath Series programs to new markets and demographics.
- Ongoing: Establishment of community wellness centers in strategic locations.
- Ongoing: Partnerships with correctional facilities to implement the Living Breath Project.
- Upcoming: Development and launch of a digital platform for online delivery of the Living Breath Process (timeline: 1-2 years).
- Upcoming: Launch of corporate wellness programs based on the Living Breath Process (timeline: 1-2 years).
Riskler
- Potential: Competition from established players in the wellness market.
- Potential: Changes in regulations related to addiction treatment and mental health.
- Potential: Economic downturn affecting consumer spending on wellness products.
- Potential: Technological advancements disrupting the market.
- Ongoing: Limited financial resources and lack of profitability.
Büyüme Fırsatları
- Expansion of the Living Breath Series: The company can expand its Living Breath Series of programs to reach a broader audience. This includes developing new products, educational materials, and services tailored to specific demographics and needs. The global self-help market is projected to reach $14 billion by 2027, providing a significant opportunity for growth. Timeline: Ongoing.
- Establishment of Community Wellness Centers: Drug Free Solution can establish community wellness centers in strategic locations to provide access to its Living Breath Process and related services. These centers can serve as hubs for community engagement and offer a range of wellness programs. The market for community-based wellness programs is growing, driven by increasing awareness of the importance of social support in mental health. Timeline: Ongoing.
- Partnerships with Correctional Facilities: The company can partner with correctional facilities to implement its Living Breath Project and reduce addiction and incarceration rates. This includes providing training, education, and support networks for inmates and staff. The market for correctional healthcare services is substantial, with significant potential for innovative programs that address addiction and mental health. Timeline: Ongoing.
- Digital Platform Development: Creating a digital platform to deliver the Living Breath Process online can significantly expand the company's reach and accessibility. This platform can offer virtual coaching, online courses, and interactive tools to support emotional wellness. The digital health market is experiencing rapid growth, with increasing adoption of telehealth and virtual wellness solutions. Timeline: 1-2 years.
- Corporate Wellness Programs: Offering corporate wellness programs based on the Living Breath Process can tap into the growing demand for employee mental health support. These programs can help reduce stress, improve productivity, and enhance employee well-being. The corporate wellness market is expanding, with companies increasingly investing in mental health benefits for their employees. Timeline: 1-2 years.
Fırsatlar
- Expansion of Living Breath Series programs.
- Establishment of community wellness centers.
- Partnerships with correctional facilities.
- Development of a digital platform for online delivery.
Tehditler
- Competition from established players in the wellness market.
- Changes in regulations related to addiction treatment and mental health.
- Economic downturn affecting consumer spending on wellness products.
- Potential for technological advancements to disrupt the market.
Rekabet Avantajları
- Proprietary Living Breath Process technology.
- Focus on community-based wellness initiatives.
- Potential for partnerships with correctional facilities.
- Brand recognition within the emotional wellness market.
DSOL Hakkında
Drug Free Solution, Inc., formerly known as Living Breath Project, Inc., is a lifestyle company founded to provide emotional wellness solutions. The company's core offering is the Living Breath Process, a three-step method incorporating self-analysis, breathwork, and language techniques. This process is designed to address various markets, including addiction prevention, self-help, emotional wellness, and general lifestyle enhancement. Drug Free Solution offers the Living Breath Series, a suite of programs, products, education, and services centered around this proprietary process. The company's Living Breath Project aims to establish community wellness centers, wellness homes, and correctional facility support networks. These initiatives combine the company's offerings to reduce addiction and incarceration rates in the United States. Incorporated in January 2014, Drug Free Solution, Inc. is based in El Segundo, California, and continues to develop and expand its reach within the emotional wellness market.
Ne Yaparlar
- Delivers proprietary emotional wellness technology known as Living Breath Process.
- Offers a three-step process combining self-analysis, breath, and language.
- Targets addiction/prevention, self-help, emotional wellness, and lifestyle markets.
- Provides the Living Breath Series of programs with products, education, and services.
- Focuses on creating community wellness centers and wellness homes.
- Establishes correctional facility support networks and centers.
- Aims to diminish addiction and incarceration rates in the United States.
İş Modeli
- Sales of Living Breath Series programs, products, and services.
- Revenue from training and education programs related to the Living Breath Process.
- Partnerships with community wellness centers and correctional facilities.
- Potential revenue from corporate wellness programs.
Sektör Bağlamı
Drug Free Solution, Inc. operates within the healthcare information services sector, which is experiencing growth due to increasing awareness of mental health and the demand for accessible wellness solutions. The market is competitive, with numerous companies offering various approaches to emotional wellness and addiction prevention. Competitors include companies like AHGIF (American Green, Inc.), CBSTF (Cannabics Pharmaceuticals Inc.), CYYNF (Canna-Global Acquisition Corp), ITHUF (Isracann Biosciences Inc.), and LEEEF (Laredo Oil Inc.). Drug Free Solution differentiates itself through its proprietary Living Breath Process and its focus on community-based wellness initiatives.
Kilit Müşteriler
- Individuals seeking addiction prevention and self-help solutions.
- Community wellness centers and organizations.
- Correctional facilities and support networks.
- Corporations looking to improve employee wellness.
Finansallar
Grafik & Bilgi
Drug Free Solution, Inc. (DSOL) hisse senedi fiyatı: Price data unavailable
Son Haberler
-
Stocks That Hit 52-Week Lows On Tuesday
· 24 Mar 2020
-
Stocks That Hit 52-Week Highs On Tuesday
· 24 Mar 2020
Analist Konsensüsü
Fikir Birliği Derecelendirmesi
DSOL için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.
Fiyat Hedefleri
DSOL için Wall Street fiyat hedefi analizi.
MoonshotScore
Bu puan ne anlama geliyor?
MoonshotScore, DSOL'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.
Yönetim: Jessica Bass
CEO
Jessica Bass serves as the CEO of Drug Free Solution, Inc. Her background includes experience in the wellness and lifestyle sectors. She has a track record of developing and implementing innovative programs focused on emotional well-being and addiction prevention. Her expertise lies in creating community-based initiatives and partnerships to promote holistic health. She is committed to expanding the reach of the Living Breath Process and making it accessible to a wider audience.
Sicil: Under Jessica Bass's leadership, Drug Free Solution, Inc. has focused on expanding its Living Breath Series programs and establishing partnerships with community organizations. She has overseen the development of new educational materials and services related to the Living Breath Process. Her strategic decisions have aimed to increase the company's visibility and impact within the emotional wellness market.
DSOL OTC Piyasa Bilgileri
The OTC Other tier represents the lowest tier of the OTC market, indicating that Drug Free Solution, Inc. may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited trading volume and may not be subject to the same level of regulatory oversight as companies listed on major exchanges like the NYSE or NASDAQ. Investing in companies on the OTC Other tier carries significant risks due to the potential for limited information and liquidity.
- OTC Katmanı: OTC Other
- Açıklama Durumu: Unknown
- Limited financial disclosure increases the risk of investing in DSOL.
- Low trading volume and wide bid-ask spread can lead to price volatility.
- The OTC Other tier indicates a higher risk of fraud or manipulation.
- Lack of regulatory oversight compared to major exchanges.
- Potential for delisting or suspension of trading.
- Verify the company's financial statements and SEC filings (if any).
- Research the background and experience of the company's management team.
- Assess the company's business model and competitive landscape.
- Evaluate the company's revenue streams and profitability.
- Check for any legal or regulatory issues.
- Monitor trading volume and price volatility.
- Consult with a financial advisor before investing.
- The company has a registered business address in El Segundo, California.
- The company has a CEO (Jessica Bass) with a background in the wellness sector.
- The company has a proprietary technology (Living Breath Process).
- The company has been in operation since 2014 (formerly Living Breath Project, Inc.).
DSOL Healthcare Hisse Senedi SSS
DSOL için değerlendirilmesi gereken temel faktörler nelerdir?
Drug Free Solution, Inc. (DSOL) şu anda yapay zeka skoru 45/100, düşük puanı gösteriyor. Temel güçlü yan: Proprietary Living Breath Process technology.. İzlenmesi gereken birincil risk: Potential: Competition from established players in the wellness market.. Bu bir finansal tavsiye değildir.
DSOL MoonshotScore'u nedir?
DSOL şu anda MoonshotScore'da 45/100 (Derece D) alıyor, bu da düşük derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.
DSOL verileri ne sıklıkla güncellenir?
DSOL fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.
Analistler DSOL hakkında ne diyor?
DSOL için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.
DSOL'a yatırım yapmanın riskleri nelerdir?
DSOL için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Competition from established players in the wellness market.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.
DSOL'ın P/E oranı nedir?
DSOL için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için DSOL'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.
DSOL aşırı değerli mi, yoksa düşük değerli mi?
Drug Free Solution, Inc. (DSOL)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.
DSOL'ın temettü verimi nedir?
Drug Free Solution, Inc. (DSOL) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.
Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.
Resmi Kaynaklar
Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.
- Information is based on available company descriptions and limited financial data.
- OTC market data may be less reliable than data from major exchanges.
- AI analysis is pending and may provide additional insights.